Advertisement

Topics

Orthocell Receives CE Mark for CelGro®

20:23 EST 8 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Approved for marketing and distribution in EU for dental bone and soft tissue regeneration First product of a diverse suite of collagen medical devices to be commercialised from Orthocell’s CelGro®...

Other Sources for this Article

General enquiries
Orthocell Limited
Paul Anderson, +61 8 9360 2888
Managing Director
paulanderson@orthocell.com.au
or
Investor and Media enquiries
WE Buchan
Ben Walsh, + 61 411 520 012
bwalsh@buchanwe.com.au

NEXT ARTICLE

More From BioPortfolio on "Orthocell Receives CE Mark for CelGro®"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Dentistry
Dentistry is the study, management and treatment of diseases and conditions affecting the mouth, jaw, teeth and their supporting tissues (Oxford Medical Dictionary) The work of a dentist ranges from regular patient check-up to orthodontics and surgery....

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...